Trv Gp Vi
Latest statistics and disclosures from Trv Gp Vi's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SEPN, Seaport Therapeutics, RAPP, TNGX, and represent 100.00% of Trv Gp Vi's stock portfolio.
- Added to shares of these 1 stock: Seaport Therapeutics (+$45M).
- Started 1 new stock position in Seaport Therapeutics.
- Trv Gp Vi was a net buyer of stock by $45M.
- Trv Gp Vi has $232M in assets under management (AUM), dropping by 71.30%.
- Central Index Key (CIK): 0001990716
Tip: Access up to 7 years of quarterly data
Positions held by Trv Gp Vi consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Trv Gp Vi
Trv Gp Vi holds 4 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Septerna (SEPN) | 60.7 | $141M | 4.2M | 33.49 |
|
|
| Seaport Therapeutics | 19.3 | $45M | NEW | 2.1M | 21.72 |
|
| Rapport Therapeutics (RAPP) | 17.4 | $40M | 969k | 41.67 |
|
|
| Tango Therapeutics (TNGX) | 2.6 | $6.1M | 194k | 31.26 |
|
Past Filings by Trv Gp Vi
SEC 13F filings are viewable for Trv Gp Vi going back to 2024
- Trv Gp Vi 2026 Q2 filed Aug. 10, 2026
- Trv Gp Vi 2026 Q1 filed May 7, 2026
- Trv Gp Vi 2025 Q4 filed Feb. 13, 2026
- Trv Gp Vi 2025 Q3 filed Nov. 13, 2025
- Trv Gp Vi 2025 Q2 filed Aug. 8, 2025
- Trv Gp Vi 2025 Q1 filed May 9, 2025
- Trv Gp Vi 2024 Q4 filed Feb. 13, 2025